Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


1 Aliment Pharmacol Ther
1 Am J Surg
2 Dig Dis Sci
2 Eur J Gastroenterol Hepatol
1 Gastroenterol Hepatol
4 Gut
1 Inflamm Bowel Dis
1 J Crohns Colitis

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Aliment Pharmacol Ther

  1. KOTZE PG, Ma C, Almutairdi A, Al-Darmaki A, et al
    Real-world clinical, endoscopic and radiographic efficacy of vedolizumab for the treatment of inflammatory bowel disease.
    Aliment Pharmacol Ther. 2018 Jul 31. doi: 10.1111/apt.14919.
    PubMed     Text format     Abstract available

    Am J Surg

  2. COLOMBO F, Pellino G, Selvaggi F, Corsi F, et al
    Minimally invasive surgery and stoma-related complications after restorative proctocolectomy for ulcerative colitis. A two-centre comparison with open approach.
    Am J Surg. 2018 Jul 24. pii: S0002-9610(18)30439.
    PubMed     Text format     Abstract available

    Dig Dis Sci

  3. LING C, Gavin M, Hanson J, McCarthy DM, et al
    Progressive Epigastric Pain with Abnormal Liver Tests in a Patient with Crohn's Disease: Don't DILI Dally.
    Dig Dis Sci. 2018;63:1751-1755.
    PubMed     Text format    

  4. LIAN L, Huang Q, Zhang L, Qin H, et al
    Anti-fibrogenic Potential of Mesenchymal Stromal Cells in Treating Fibrosis in Crohn's Disease.
    Dig Dis Sci. 2018;63:1821-1834.
    PubMed     Text format     Abstract available

    Eur J Gastroenterol Hepatol

  5. SIMSEK M, Seinen ML, de Boer NKH
    Nodular regenerative hyperplasia in inflammatory bowel disease patients with allopurinol-thiopurine cotherapy.
    Eur J Gastroenterol Hepatol. 2018 Jul 30. doi: 10.1097/MEG.0000000000001218.
    PubMed     Text format    

  6. DE CHAMBRUN GP, Nachury M, Funakoshi N, Gerard R, et al
    Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis.
    Eur J Gastroenterol Hepatol. 2018 Jul 26. doi: 10.1097/MEG.0000000000001223.
    PubMed     Text format     Abstract available

    Gastroenterol Hepatol

  7. NUNEZ-GOMEZ L, Mesonero-Gismero F, Albillos-Martinez A, Lopez-Sanroman A, et al
    Anti-tumor necrosis factor agents in Crohn's disease and ulcerative colitis: Beyond luminal disease.
    Gastroenterol Hepatol. 2018 Jul 24. pii: S0210-5705(18)30195.
    PubMed     Text format     Abstract available


  8. MAO R, Chen Y, Xie X, Chen M, et al
    Gastrointestinal ultrasound in inflammatory bowel disease: experience from the Chinese IBD Elite Union.
    Gut. 2018 Jul 27. pii: gutjnl-2018-317070. doi: 10.1136/gutjnl-2018-317070.
    PubMed     Text format    

  9. KOTZE PG, Shen B, Lightner A, Yamamoto T, et al
    Modern management of perianal fistulas in Crohn's disease: future directions.
    Gut. 2018;67:1181-1194.
    PubMed     Text format     Abstract available

  10. BISSCHOPS R, Bessissow T, Joseph JA, Baert F, et al
    Chromoendoscopy versus narrow band imaging in UC: a prospective randomised controlled trial.
    Gut. 2018;67:1087-1094.
    PubMed     Text format     Abstract available

  11. ZHOU G, Yu L, Fang L, Yang W, et al
    CD177(+) neutrophils as functionally activated neutrophils negatively regulate IBD.
    Gut. 2018;67:1052-1063.
    PubMed     Text format     Abstract available

    Inflamm Bowel Dis

  12. WATT PJ, Irving MA
    A Diagnosis of Inflammatory Bowel Disease and Access to Psychotherapy: Rural Patients Who Accept Treatment Report Psychosomatic Benefits.
    Inflamm Bowel Dis. 2018 Jul 21. pii: 5056917. doi: 10.1093.
    PubMed     Text format    

    J Crohns Colitis

  13. TAXONERA C, Ponferrada A, Riestra S, Bermejo F, et al
    Serial Tuberculin Skin Tests Improves the Detection of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease.
    J Crohns Colitis. 2018 Jul 21. pii: 5056955. doi: 10.1093.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.